Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
BetterLife Pharma Inc. (BETRF) had Debt to Capital Ratio of -0.02 for the most recently reported fiscal quarter, ending 2025-10-31.
| Income Statement Financials | |
-- |
|
$-0.29M |
|
-- |
|
-- |
|
$0.31M |
|
$-0.31M |
|
$0.01M |
|
$-0.30M |
|
$-0.30M |
|
$-0.30M |
|
$-0.30M |
|
$-0.30M |
|
$-0.30M |
|
$-0.31M |
|
$-0.31M |
|
151.86M |
|
151.86M |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$0.21M |
|
-- |
|
-- |
|
$0.21M |
|
$4.58M |
|
$0.07M |
|
$0.07M |
|
$4.65M |
|
$-4.44M |
|
$-4.44M |
|
$-4.44M |
|
151.90M |
|
| Cash Flow Statement Financials | |
$-0.14M |
|
-- |
|
$0.14M |
|
$0.01M |
|
$0.01M |
|
$-0.00M |
|
$0.12M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.05 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-0.02 |
-0.11 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.14M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
6.81% |
|
6.81% |
|
-144.31% |
|
6.92% |
|
$-0.03 |
|
$-0.00 |
|
$-0.00 |
|